Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ELDER PHARMA vs ADCOCK INGRAM (S. Africa) - Comparison Results

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 ELDER PHARMA   ADCOCK INGRAM
EQUITY SHARE DATA
    ELDER PHARMA
Jun-14
ADCOCK INGRAM
Jun-14
ELDER PHARMA/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs380320-   
Low Rs188231-   
Sales per share (Unadj.) Rs489.295.3-  
Earnings per share (Unadj.) Rs-3.2-24.0-  
Cash flow per share (Unadj.) Rs14.4-19.9-  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs376.574.8-  
Shares outstanding (eoy) m20.54168.78-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.62.9 20.1%   
Avg P/E ratio x-89.3-11.5 777.7%  
P/CF ratio (eoy) x19.7-13.9 -142.2%  
Price / Book Value ratio x0.83.7 20.5%  
Dividend payout %00-   
Avg Mkt Cap Rs m5,83246,551 12.5%   
No. of employees `000NA4.3 0.0%   
Total wages/salary Rs m2,1792,922 74.6%   
Avg. sales/employee Rs Th03,747.7-  
Avg. wages/employee Rs Th0680.6-  
Avg. net profit/employee Rs Th0-944.3-  
INCOME DATA
Net Sales Rs m10,04816,089 62.5%  
Other income Rs m257113 227.7%   
Total revenues Rs m10,30516,201 63.6%   
Gross profit Rs m2,921-2,788 -104.8%  
Depreciation Rs m361694 52.0%   
Interest Rs m2,756436 632.5%   
Profit before tax Rs m60-3,806 -1.6%   
Minority Interest Rs m0-11 -0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m125238 52.6%   
Profit after tax Rs m-65-4,054 1.6%  
Gross profit margin %29.1-17.3 -167.7%  
Effective tax rate %209.1-6.2 -3,346.8%   
Net profit margin %-0.6-25.2 2.6%  
BALANCE SHEET DATA
Current assets Rs m9,24011,784 78.4%   
Current liabilities Rs m9,9986,630 150.8%   
Net working cap to sales %-7.532.0 -23.5%  
Current ratio x0.91.8 52.0%  
Inventory Days Days128111 115.7%  
Debtors Days Days602124 485.6%  
Net fixed assets Rs m13,6426,869 198.6%   
Share capital Rs m20675 275.3%   
"Free" reserves Rs m7,5280-   
Net worth Rs m7,73312,628 61.2%   
Long term debt Rs m4,8894,438 110.2%   
Total assets Rs m22,88223,855 95.9%  
Interest coverage x1.0-7.7 -13.2%   
Debt to equity ratio x0.60.4 179.9%  
Sales to assets ratio x0.40.7 65.1%   
Return on assets %11.8-15.2 -77.5%  
Return on equity %-0.8-32.1 2.6%  
Return on capital %22.3-19.8 -112.6%  
Exports to sales %3.10-   
Imports to sales %0.40-   
Net fx Rs m1810-   
CASH FLOW
From Operations Rs m11,7541,373 855.9%  
From Investments Rs m-561-422 132.9%  
From Financial Activity Rs m-6,7624,028 -167.9%  
Net Cashflow Rs m5,4664,979 109.8%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 4.42 Rs / ZAR

Compare ELDER PHARMA With: MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare ELDER PHARMA With: DIVIS LABORATORIES  ANUH PHARMA  UNJHA FORMUL  BANDARAM PHARMA PACKTECH  HIKAL.  



Today's Market

Sensex Today Trades Lower | Metal & PSB Stocks Shine | TCS, Apollo Tyre Drop 3% Sensex Today Trades Lower | Metal & PSB Stocks Shine | TCS, Apollo Tyre Drop 3%(10:30 am)

Asian shares slipped before a Bank of Japan policy decision where authorities are likely to bring an end to the world's last negative rates regime.